A randomized, open-label, multicenter trial comparing once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial

Journal of Opioid Management

Volumn 3, Issue 1, 2007, Pages 35-43

  Rauck, Richard L ^a   Bookbinder, Stephen A ^b   Bunker, Timothy R ^c   Alftine, Christopher D ^d   Gershon, Steven ^e   de Jong, Egbert ^f   Negro Vilar, Andres ^g   Ghalie, Richard ^g  

^a Carolinas Pain Institute   (United States)

^b Ocala Rheumatology Research Center   (United States)

^c The Birmingham Pain Center   (United States)

^d Medford Clinic   (United States)

^e Advanced Pain Management and Rehabilitation PC   (United States)

^f Organon USA   (United States)

^g LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

ACTION trial; AVINZA; Chronic pain; Low back pain; Morphine sulfate; Oxycodone HCl; Physical functioning; Quality of life

Indexed keywords

MORPHINE SULFATE; OPIATE; OXYCODONE; MORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; EXTENDED RELEASE FORMULATION; FUNCTIONAL ASSESSMENT; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MENTAL HEALTH; MULTICENTER STUDY; OPEN STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOCIAL INTERACTION; TABLET; CHRONIC DISEASE; DELAYED RELEASE FORMULATION; HEALTH SURVEY; MIDDLE AGED; WORK CAPACITY;

ADULT; AGED; ANALGESICS, OPIOID; CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; HEALTH SURVEYS; HUMANS; LOW BACK PAIN; MIDDLE AGED; MORPHINE; OXYCODONE; QUALITY OF LIFE; QUESTIONNAIRES; WORK CAPACITY EVALUATION;

EID: 34047158582     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2007.0037     Document Type: Article

References (14)

1. Rauck RL, Bookbinder SA, Bunker TR, et al.: The ACTION Study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA®) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin®) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag. 2006; 2(3):155-166.
2. Rauck RL, Bookbinder SA, Bunker TR, et al.: A randomized, open-label study of once-a-day AVINZAO (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial. J Opioid Manag. 2006; 2(6): 325-333.
3. Ware J Jr, Kositiski M, Keller SD: A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3): 220-233.
4. Lerner D, Amick BC, Rogers WH, et al.: The Work Limitations Questionnaire. Med Care. 2001; 39(1): 72-85.
5. Luo X, Pietrobon R, Sun SX, et al.: Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine. 2004; 29(1): 79-86.
6. Allan DB, Waddell G: A historical perspective on low back pain and disability. Acta Orthop Scand. 1989; 60(Suppl 234): 1-23.
7. Moulin DE: Systemic drug treatment for chronic musculoskeletal pain. Clin J Pain. 2001; 17(4 Suppl): S86-S93.
8. Moulin DE, Iezzi A, Amireh R, et al.: Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996; 347(8995): 143-147.
9. McCarberg BH, Barkin RL: Long-acting opioids for chronic pain: Pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther. 2001; 8(3): 181-186.
10. Peloso PM, Bellamy N, Bensen W, et al.: Double-blind randomized placebo-controlled trial of controlled-release codeine in the treatment of osteoarthritis of the hip and knee. J Rheumatol. 2000; 27: 764-771.
11. Dworkin RH, Turk DC, Farrar JT, et al.: Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005; 113(1-2): 9-19.
12. Caldwell JR, Rapoport RJ, Davis JC, et al.: Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage. 2002; 23(4): 278-291.
13. Adams EH, Chwiecko P, Ace-Wagoner Y, et al.: A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions - The ACCPT Study. Pain Pract. 2006; 6(4): 254-264.
14. Nicholson B, Ross E, Sasaki J, et al.: Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe non-malignant pain. Curr Med Res Op. 2006; 22(8): 1503-1514.